Crisostomo Lacano
Diagnostic Radiology · Rockledge, FLNPI 1063486819
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 59 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 11.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $2,471 and has fallen 64.2% since, to $885 in 2025. Among diagnostic radiology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 59 payments — averaging $116.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$804
- Johnson & Johnson$520
- GSK$441
- E.r. Squibb & Sons, L.L.C.$415
- Daiichi Sankyo Inc.$249
- Amgen$249
- plus $4K from 28 others
What the payments were for
- Food & beverage$6,893100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 7 | $804 |
| Johnson & Johnson | 4 | $520 |
| GSK | 4 | $441 |
| E.r. Squibb & Sons, L.L.C. | 4 | $415 |
| Daiichi Sankyo Inc. | 2 | $249 |
| Amgen | 2 | $249 |
| EMD Serono, Inc. | 2 | $245 |
| Regeneron Healthcare Solutions, Inc. | 2 | $241 |
| Gilead(2 entities) | 2 | $241 |
| Seagen Inc. | 2 | $239 |
| Sanofi | 2 | $235 |
| Incyte Corporation | 2 | $230 |
| Merck | 2 | $213 |
| Pfizer | 2 | $199 |
| Novocure Inc. | 1 | $158 |
| Dendreon Pharmaceuticals LLC | 1 | $150 |
| Genentech USA, Inc. | 1 | $146 |
| Blueprint Medicines Corporation | 1 | $127 |
| Pharmacosmos Therapeutics Inc. | 1 | $125 |
| Bayer | 1 | $124 |
| Recordati_rare_diseases_inc. | 1 | $124 |
| Syndax Pharmaceuticals, Inc. | 1 | $124 |
| Exelixis Inc. | 1 | $123 |
| Jazz Pharmaceuticals Inc. | 1 | $123 |
| Genmab U.S., Inc. | 1 | $122 |
| Sobi, Inc | 1 | $121 |
| Eisai Inc. | 1 | $121 |
| Lilly USA, LLC | 1 | $111 |
| Rigel Pharmaceuticals, Inc. | 1 | $108 |
| Karyopharm Therapeutics Inc. | 1 | $103 |
| Geron Corporation | 1 | $102 |
| Servier Pharmaceuticals LLC | 1 | $88 |
| Beigene USA, Inc. | 1 | $88 |
| ADC Therapeutics America, Inc. | 1 | $82 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,893 in reported general payments places this provider in the 90th percentile of 2,215 diagnostic radiology providers in Florida.
Other diagnostic radiology in Rockledge
- Yair SafrielClearwater$660K
- Constantino PenaMiami$586K
- Justin WhisenantSt Petersburg$503K
- Michael YuzFort Lauderdale$398K
- Barry KatzenMiami$313K
- Andrew NiekampMiami$250K
- Homer HattenVero Beach$195K
- Mario ZaritzkyPlantation$154K
- Joanne WernickiVero Beach$153K
- Jamie CaraccioloTampa$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.